A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- AbbVie
- Study ID
- NCT03368859
- Phase
- PHASE2
- Status
- Terminated
Conditions
- Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Leucovorin — DRUGIntravenous
- Fluorouracil - bolus — DRUGIntravenous
- Bevacizumab — DRUGIntravenous
- Fluorouracil - infusion — DRUGIntravenous
- ABT-165 — DRUGIntravenous
- Irinotecan — DRUGIntravenous
Study Details
A study to evaluate the efficacy and tolerability of ABT-165 plus FOLFIRI compared to bevacizumab plus FOLFIRI in participants with previously treated metastatic adenocarcinoma of the colon or rectum.
Key Dates
- Start date
- Mar 20, 2018
- Status verified
- Jan 2021
- Primary completion
- Dec 18, 2019
- Completion
- Dec 18, 2019
Study Design
- Enrollment
- 70 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ABT-165 plus FOLFIRIABT-165 plus FOLFIRI (irinotecan, leucovorin, fluorouracil).
- Active Comparator: Bevacizumab plus FOLFIRIBevacizumab plus FOLFIRI (irinotecan, leucovorin, fluorouracil).
Primary Outcome Measure
Progression Free Survival (PFS) [ Time Frame: Follow up continued until the first occurrence of radiographic progression, death from any cause or termination of the study; median follow-up time was 25.6(0.3-64.4) and 37.6(0.3-66.3) weeks in ABT-165 plus FOLFIRI and Bevacizumab + FOLFIRI, respectively ]
Locations (46)
Find similar trials in Chandler, AZ
Related Studies
- Effects of Oncological Treatment During Pregnancy on Mother and ChildRecruiting · University Hospital, Gasthuisberg · Camden, New Jersey
- Establishment of a Lifetime of Cohort of Adults Surviving Childhood CancerRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee
- Arizona Cancer Center Biospecimen RepositoryRecruiting · University of Arizona · Tucson, Arizona
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama